Zobrazeno 1 - 10
of 67
pro vyhledávání: '"I N, van Schaik"'
Autor:
S. R. M. Bus, L. Zambreanu, A. Abbas, Y. A. Rajabally, R. D. M. Hadden, R. J. de Haan, C. A. J. M. de Borgie, M. P. Lunn, I. N. van Schaik, F. Eftimov, on behalf of the OPTIC study group
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-18 (2021)
Abstract Background International guidelines recommend either intravenous immunoglobulin (IVIg) or corticosteroids as first-line treatment for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). IVIg treatment usually leads to rapid imp
Externí odkaz:
https://doaj.org/article/86106c2f745f4ee7aa575fbdc28612b9
Autor:
G. G. A. van Lieverloo, A. Al‐Soudi, L. Wieske, P. L. Klarenbeek, D. C. Anang, M. E. Adrichem, I. Niewold, B. D. C. van Schaik, A. H. C. van Kampen, I. N. van Schaik, N. de Vries, F. Eftimov
Publikováno v:
Journal of the peripheral nervous system, 28(1), 69-78. Wiley-Blackwell
The immunopathophysiological mechanisms underlying chronic inflammatory demyelinating polyneuropathy (CIDP) in an individual patient are largely unknown. Better understanding of these mechanisms may aid development of biomarkers and targeted therapie
Autor:
Orell Mielke, H.-P. Hartung, Billie L. Durn, R. Mallick, Vera Bril, Richard A. Lewis, I. N. van Schaik, John-Philip Lawo, I. S. J. Merkies, David R. Cornblath, Gen Sobue
Publikováno v:
European Journal of Neurology, 27(1), 196-203. Wiley
Background and purpose Chronic inflammatory demyelinating polyneuropathy (CIDP) causes weakness which adversely impacts function and quality of life (QOL). CIDP often requires long-term management with intravenous or subcutaneous immunoglobulin. The
Autor:
P.A. van Doorn, W.L. van der Pol, H S Goedee, I. N. van Schaik, Max E. Adrichem, Hester F. Lingsma, S. R. M. Bus, R. van der Veen, Bart C. Jacobs, Merel C. Broers, Ilse M. Lucke, G. G. A. van Lieverloo, Carina Bunschoten, Luuk Wieske, Filip Eftimov
Publikováno v:
Journal of Neurology, 269(2), 945-955. D. Steinkopff-Verlag
Journal of Neurology
Journal of Neurology
Objective To assess clinical outcome in treatment-naive patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Methods We included adult treatment-naive patients participating in the prospective International CIDP Outcome Stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73c57afcfd01cbdd8d4057b54b99bd1b
https://pure.eur.nl/en/publications/2849943e-ce21-4132-8d28-6c64469113ec
https://pure.eur.nl/en/publications/2849943e-ce21-4132-8d28-6c64469113ec
Autor:
Luuk Wieske, Filip Eftimov, Max E. Adrichem, S. R. M. Bus, R. Hadden, Camiel Verhamme, I. N. van Schaik, Hassen Mohammed
Publikováno v:
European journal of neurology, 27(3), 506-513. Wiley-Blackwell
European Journal of Neurology
European Journal of Neurology
Background and purpose We hypothesized that combining intravenous immunoglobulin (IVIg) and intravenous methylprednisolone (IVMP) leads to more frequent remission compared with IVIg alone while maintaining the fast efficacy of IVIg. In this uncontrol
Autor:
Martin Stangel, K. George, Inna Rubanovits, A. Kutschenko, Michael Schroeter, Juliane Klehmet, Tsugio Akutsu, Robert D. Henderson, S. Mumfrey, Takuya Ohkubo, Helmar C. Lehmann, Mari Auranen, Paul Bassett, Giuseppe Lauria, A. Di Muzio, Kenichi Kaida, David Yarnitsky, S. Larue, R. Gold, Fabian Klostermann, Karissa L. Gable, Ivo N. van Schaik, Gens Sobue, A Schenone, U. Sorro, Jeffrey A. Allen, S. Attarian, A. Algom, U. Chyrchel-Paszkiewicz, J. Haas, Jens Ejbye Schmidt, I. N. van Schaik, Jasper M. Morrow, Ingemar S. J. Merkies, R. Carne, C. Marquez Infante, Michael P. Lunn, Khema Sharma, E. Chi Ho Lai, Billie L. Durn, Satoshi Kuwabara, D. Kramer, David Gosal, P. MacDonald, Janneke G. J. Hoeijmakers, Giovanni Antonini, Senda Ajroud-Driss, S. Muley, Takanori Yokota, Tim Hagenacker, Eroboghene E. Ubogu, M. Kawai, Maria Salvado, Jean Pouget, Mika Saarela, John T. Kissel, Alexander Shtilbans, K. Kanai, B. Murinson, Olaf Hoffmann, Claudia Sommer, Sandro Sorbi, P. Berlit, Norman Latov, Nora A. Visser, C. G. Faber, A. Wielanek, J. Demeestere, Ericka Simpson, Ginna Gonzalez, Konrad Rejdak, C. Casanovas Pons, Alessandro Testori, Orell Mielke, T. Kalous, Alexa Cleasby, Vera Bril, J. Sussova, D. Mueller, Katrin Gross-Paju, Dale J. Lange, Nicolette C. Notermans, Florian Then Bergh, R. Talab, Kazumasa Yokoyama, M. Zibetti, C. Trebst, Marina Grandis, Miriam Freimer, E. Delmon, David R. Cornblath, Masahiro Mori, H. Onoue, Richard J. Barohn, D. Liebetanz, M. Chatzopoulos, J. Oechtering, F. Ciccocioppo, T. Rao, P. Van Damme, A. Sabet, Takashi Kanda, J. Zschuentzsch, Hans-Peter Hartung, S. Benitez, D. Aufauvre, M. Bednar, M. Tomiyama, G. Le Masson, C. D'Amour, Richard A. Lewis, Anne D. Sperfeld, I. Melamed, Lisa D. Hobson-Webb, Stefan Blum, Dario Cocito, K. Nishiyama, Daniele Cazzato, F. Bethke, Toomas Toomsoo, Said R. Beydoun, Leslie Roberts, David Walk, Josep Gamez, Masahiro Iijima, A. Jaspert-Grehl, Israel V. Drory, P. Kunc, John-Philip Lawo, C. Goerlitz, H. Johl, R. Yoon, Daniela M. Menichella, T. Lavin, Stefania Morino, K. Ohyama, Masayuki Baba, M. Antonia, Shafeeq Ladha, Claude Desnuelle, Pierre Clavelou, Andreas Meisel, Martin Vališ, Filip Eftimov, P. Baum, Sabrina Matà, Russell L. Chin, Mazen M. Dimachkie
Publikováno v:
Journal of the peripheral nervous system, 25(3), 230-237. Wiley-Blackwell
Journal of the Peripheral Nervous System
Journal of the Peripheral Nervous System
The Polyneuropathy And Treatment with Hizentra (PATH) study required subjects with chronic inflammatory demyelinating polyneuropathy (CIDP) to show dependency on immunoglobulin G (IgG) and then be restabilized on IgG before being randomized to placeb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43063fcd25f2793a6b2337f883a18156
https://pure.amc.nl/en/publications/placebo-effect-in-chronic-inflammatory-demyelinating-polyneuropathy-the-path-study-and-a-systematic-review(82ad0dca-304a-4f5e-9f95-296f8e71a555).html
https://pure.amc.nl/en/publications/placebo-effect-in-chronic-inflammatory-demyelinating-polyneuropathy-the-path-study-and-a-systematic-review(82ad0dca-304a-4f5e-9f95-296f8e71a555).html
Autor:
Francesca Gallia, Camiel Verhamme, Ivana Basta, I. N. van Schaik, Eduardo Nobile-Orazio, Pietro Emiliano Doneddu, Stojan Peric, Ana Nikolic, Luuk Wieske, Filip Eftimov, G. G. A. van Lieverloo
Publikováno v:
Journal of neurology, 265(9), 2052-2059. D. Steinkopff-Verlag
Background: Chronic inflammatory demyelinating polyneuropathy (CIDP) can be treated with corticosteroids or intravenous immunoglobulins. Various corticosteroid regimens are currently used in CIDP, but it is unknown whether they are equally efficaciou
Autor:
L. van der Hoek, Luuk Wieske, G. G. A. van Lieverloo, I. N. van Schaik, Martin Deijs, Filip Eftimov
Publikováno v:
Journal of neuroimmunology, 358:577668. Elsevier
The events triggering and/or sustaining the auto-immune response underlying chronic inflammatory demyelinating polyneuropathy (CIDP) are unknown. Similar to Guillain-Barre syndrome (GBS), a viral infection might play a role in CIDP. In this study, an
Autor:
Billie L. Durn, Orell Mielke, I.S.J. Merkies, H.-P. Hartung, David R. Cornblath, Vera Bril, J.P. Lawo, Gen Sobue, Richard A. Lewis, N. van Geloven, I. N. van Schaik, M. M. Dimachkie
Publikováno v:
Muscle & Nerve. 56:S1-S16
Patients with chronic inflammatory demyelinating polyneuropathy (CIDP) often require long-term intravenous immunoglobulin (IVIG) maintenance therapy. Subcutaneous immunoglobulin (SCIG) offers an alternative administration option with anticipated impr
Autor:
Michael Schroeter, Amgad Shebl, Leslie Roberts, Takuya Ohkubo, M. Chatzopoulos, Nan van Geloven, Robert D. Henderson, Catharina G. Faber, R. Talab, K. George, A. Kutschenko, E. Chi-Ho Lai, M. Bednar, Inna Rubanovits, Claudia Sommer, J. Oechtering, M. Tomiyama, Hans-Peter Hartung, Mari Auranen, G. Le Masson, Konrad Rejdak, Marina Grandis, Eroboghene E. Ubogu, Senda Ajroud-Driss, Tim Hagenacker, Lisa D. Hobson-Webb, Masayuki Baba, Khema Sharma, Miriam Freimer, Kazumasa Yokoyama, U. Chyrchel-Paszkiewicz, Karissa L. Gable, P. Van Damme, J. Zschuentzsch, I. N. van Schaik, S. Benitez, K. Nishiyama, J. Demeestere, Daniele Cazzato, F. Bethke, R. Carne, Gen Sobue, C. Marquez Infante, Norman Latov, David Walk, B. Murinson, Katrin Gross-Paju, Helmar C. Lehmann, M. Antonia, Ginna Gonzalez, M. Zibetti, Anne-Cécile Wielanek-Bachelet, Vera Bril, Stefania Morino, Mika Saarela, S. Mumfrey, Said R. Beydoun, Takanori Yokota, Maria Salvado, John T. Kissel, C. D'Amour, Ericka Simpson, D. Aufauvre, P. MacDonald, Orell Mielke, David R. Cornblath, Masahiro Iijima, Janneke G. J. Hoeijmakers, Nora A. Visser, Takashi Kanda, K. Kanai, Jeffrey A. Allen, Richard A. Lewis, Anne D. Sperfeld, J. Sussova, D. Mueller, A. Algom, Fabian Klostermann, I. Melamed, David Yarnitsky, J. Haas, Josep Gamez, A Schenone, P. Kunc, Ingemar S. J. Merkies, C. Trebst, F. Ciccocioppo, Ralf Gold, Vivian E. Drory, H. Onoue, Stefan Blum, P. Berlit, S. Muley, Tsugio Akutsu, T. Kalous, Michael P. Lunn, Alessandro Testori, Dale J. Lange, Giuseppe Lauria, D. Liebetanz, A. Jaspert-Grehl, Giovanni Antonini, Masahiro Mori, S. Larue, John-Philip Lawo, C. Goerlitz, H. Johl, M. Kawai, Nicolette C. Notermans, U. Sorro, R. Yoon, Daniela M. Menichella, T. Lavin, Billie L. Durn, J. Morrow, Richard J. Barohn, Dario Cocito, T. Rao, Martin Stangel, Satoshi Kuwabara, Jean Pouget, Emilien Delmont, David Gosal, Alexander Shtilbans, Sandro Sorbi, Florian Then Bergh, J. Schmidt, Shahram Attarian, Pierre Clavelou, Andreas Meisel, Sabrina Matà, Russell L. Chin, Mazen M. Dimachkie, Juliane Klehmet, K. Ohyama, Martin Vališ, Filip Eftimov, Shafeeq Ladha, A. Sabet, P. Baum, Claude Desnuelle, Kenichi Kaida, D. Kramer, Olaf Hoffmann, C. Casanovas Pons, A. Di Muzio, Ivo N. van Schaik, Toomas Toomsoo
Publikováno v:
Journal of the peripheral nervous system, 24(1), 72-79. Wiley-Blackwell
Digital.CSIC. Repositorio Institucional del CSIC
instname
Journal of the Peripheral Nervous System, 24(1), 72. Wiley-Blackwell
Journal of the Peripheral Nervous System
Digital.CSIC. Repositorio Institucional del CSIC
instname
Journal of the Peripheral Nervous System, 24(1), 72. Wiley-Blackwell
Journal of the Peripheral Nervous System
PATH study group.
In patients with chronic inflammatory demyelinating polyneuropathy (CIDP), intravenous immunoglobulin (IVIG) is recommended to be periodically reduced to assess the need for ongoing therapy. However, little is known about the e
In patients with chronic inflammatory demyelinating polyneuropathy (CIDP), intravenous immunoglobulin (IVIG) is recommended to be periodically reduced to assess the need for ongoing therapy. However, little is known about the e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7039eb5a61ad1011b5914f9a690d3c9c
https://pure.amc.nl/en/publications/restabilization-treatment-after-intravenous-immunoglobulin-withdrawal-in-chronic-inflammatory-demyelinating-polyneuropathy-results-from-the-prerandomization-phase-of-the-polyneuropathy-and-treatment-with-hizentra-study(a3597aa6-7290-41d2-9849-99a91b4daf0e).html
https://pure.amc.nl/en/publications/restabilization-treatment-after-intravenous-immunoglobulin-withdrawal-in-chronic-inflammatory-demyelinating-polyneuropathy-results-from-the-prerandomization-phase-of-the-polyneuropathy-and-treatment-with-hizentra-study(a3597aa6-7290-41d2-9849-99a91b4daf0e).html